Intracranial Hemorrhages
84
13
16
35
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.6%
3 terminated out of 84 trials
92.1%
+5.6% vs benchmark
21%
18 trials in Phase 3/4
11%
4 of 35 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 35 completed trials
Clinical Trials (84)
Personalized ViscoElastic Testing-guided Bleeding Management In Liver Surgery, Neurosurgery and Obstetrics
PREhospital Prediction of the Risk of Intracranial Hemorrhagic Injury in the Elderly Patient With a Fall
Efficacy and Safety of Antihypertensive Treatment With Mobile Stroke Units in Ultra-Early Intracerebral Hemorrhage
Andexanet Alfa: Non-interventional Study in Stroke Units in Germany (DE)
Tenecteplase (TNK) in the Treatment of Intracerebral Hemorrhage (ICH)
Arterial Pressure and Surgical Hemostasis in Elective Neurosurgery.
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
Neonatal Seizure Registry - Developmental Functional EValuation
Validation of Falls Decision Rule to Exclude Intracranial Bleeding in Geriatric Fall Patients
Efficacy and Feasibility Trial of a Portable Near Infra-Red Hematoma Imager (NIRD-HI)
AI Assisted Reader Evaluation in Acute Computed Tomography (CT) Head Interpretation
A Pilot Study on the Prevention of the Vascular RISK Related to Atrial Fibrillation After Intracranial Hemorrhage by Closing the Left Auricle
Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
Screening Emotions in Adolescents at the Hospital for mTBI
Safety and Efficacy of Aneurysms Treated With Endovascular Devices
Intracranial PrEssure Time dOse (ImPETO)
Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.
Thrombolysis in Factor Xa-inhibitors Trial
Development and Validation of a Prognostic Model for Neurocritical Patients Using Multimodal Brain Monitoring
Fibrinogen Replacement to Prevent Intracranial Haemorrhage in Ischemic Stroke Patients After Thrombolysis (FibER)